Edoxaban Dose Adjustment and Age-Associated Outcomes in Patients With Atrial Fibrillation Post-Transcatheter Aortic Valve Replacement. [PDF]
Van Mieghem NM +10 more
europepmc +1 more source
Research Misconduct: Dabigatran, Rivaroxaban, Apixaban, Edoxaban
Jorge H Ramírez
openalex +1 more source
Economic Evaluation of Direct Oral Anticoagulants Versus Low-Molecular Weight Heparin for Cancer-Associated Thrombosis in a Thai University-Affiliated Hospital. [PDF]
Chaiwattanakowit T +4 more
europepmc +1 more source
Assess the reporting quality of randomized controlled clinical trials exploring the efficacy and safety of new anticoagulants versus warfarin in patients with atrial fibrillation based on CONCORT statement [PDF]
Μαντζουράτου, Πολυξένη Δ.
core +1 more source
Dabigatran and Edoxaban in the Repair of an Abnormal Cleft in the Right Wall of the Ascending Aorta: A Case Report. [PDF]
Takeuchi H.
europepmc +1 more source
Evaluating the impact of a structured medication optimisation review on prescribing patterns and bleeding risk among patients prescribed direct oral anticoagulants (DOACs): a difference-in-differences study. [PDF]
Camacho EM +7 more
europepmc +1 more source
Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation† [PDF]
Michelle L. O’Donoghue +11 more
openalex +1 more source
Predictors of Direct Oral Anticoagulant Use in Northern Italy: A Population-Based Study. [PDF]
Ojeda-Fernández L +6 more
europepmc +1 more source

